Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

In vitro and in vivo Efficacy of a Synergistic Combination of Itraconazole and Verapamil Against Aspergillus fumigatus.

Zeng Q, Zhang Z, Chen P, Long N, Lu L, Sang H.

Front Microbiol. 2019 Jun 7;10:1266. doi: 10.3389/fmicb.2019.01266. eCollection 2019.

3.

An in vitro and in vivo study on the synergistic effect and mechanism of itraconazole or voriconazole alone and in combination with tetrandrine against Aspergillus fumigatus.

Li SX, Song YJ, Zhang LL, Shi JP, Ma ZL, Guo H, Dong HY, Li YM, Zhang H.

J Med Microbiol. 2015 Sep;64(9):1008-20. doi: 10.1099/jmm.0.000120. Epub 2015 Jul 9.

PMID:
26296880
4.

Comparison Between Etest and Broth Microdilution Methods for Testing Itraconazole-Resistant Aspergillus fumigatus Susceptibility to Antifungal Combinations.

Denardi LB, Keller JT, de Azevedo MI, Oliveira V, Piasentin FB, Severo CB, Santurio JM, Alves SH.

Mycopathologia. 2018 Apr;183(2):359-370. doi: 10.1007/s11046-017-0208-7. Epub 2017 Oct 9.

PMID:
28994001
5.

Berberine and itraconazole are not synergistic in vitro against Aspergillus fumigatus isolated from clinical patients.

Lei G, Dan H, Jinhua L, Wei Y, Song G, Li W.

Molecules. 2011 Nov 3;16(11):9218-33. doi: 10.3390/molecules16119218.

6.

A Novel Zn2-Cys6 Transcription Factor AtrR Plays a Key Role in an Azole Resistance Mechanism of Aspergillus fumigatus by Co-regulating cyp51A and cdr1B Expressions.

Hagiwara D, Miura D, Shimizu K, Paul S, Ohba A, Gonoi T, Watanabe A, Kamei K, Shintani T, Moye-Rowley WS, Kawamoto S, Gomi K.

PLoS Pathog. 2017 Jan 4;13(1):e1006096. doi: 10.1371/journal.ppat.1006096. eCollection 2017 Jan.

7.

Erg4A and Erg4B Are Required for Conidiation and Azole Resistance via Regulation of Ergosterol Biosynthesis in Aspergillus fumigatus.

Long N, Xu X, Zeng Q, Sang H, Lu L.

Appl Environ Microbiol. 2017 Feb 1;83(4). pii: e02924-16. doi: 10.1128/AEM.02924-16. Print 2017 Feb 15.

9.

Phenotypic plasticity and the evolution of azole resistance in Aspergillus fumigatus; an expression profile of clinical isolates upon exposure to itraconazole.

Hokken MWJ, Zoll J, Coolen JPM, Zwaan BJ, Verweij PE, Melchers WJG.

BMC Genomics. 2019 Jan 9;20(1):28. doi: 10.1186/s12864-018-5255-z.

10.

Synergistic Effects of Tetrandrine with Posaconazole Against Aspergillus fumigatus.

Li SX, Song YJ, Jiang L, Zhao YJ, Guo H, Li DM, Zhu KJ, Zhang H.

Microb Drug Resist. 2017 Sep;23(6):674-681. doi: 10.1089/mdr.2016.0217. Epub 2017 Jan 12.

PMID:
28080217
11.

Comparison of azoles against aspergilli in vitro and in an experimental model of pulmonary aspergillosis.

Schmitt HJ, Edwards F, Andrade J, Niki Y, Armstrong D.

Chemotherapy. 1992;38(2):118-26.

PMID:
1317280
12.

First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.

Özmerdiven GE, Ak S, Ener B, Ağca H, Cilo BD, Tunca B, Akalın H.

J Infect Chemother. 2015 Aug;21(8):581-6. doi: 10.1016/j.jiac.2015.04.012. Epub 2015 May 14.

PMID:
26048062
13.
14.

Clinical implications of globally emerging azole resistance in Aspergillus fumigatus.

Meis JF, Chowdhary A, Rhodes JL, Fisher MC, Verweij PE.

Philos Trans R Soc Lond B Biol Sci. 2016 Dec 5;371(1709). pii: 20150460. doi: 10.1098/rstb.2015.0460. Review.

15.

High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole.

Burgel PR, Baixench MT, Amsellem M, Audureau E, Chapron J, Kanaan R, Honoré I, Dupouy-Camet J, Dusser D, Klaassen CH, Meis JF, Hubert D, Paugam A.

Antimicrob Agents Chemother. 2012 Feb;56(2):869-74. doi: 10.1128/AAC.05077-11. Epub 2011 Nov 28.

16.

Aspergillus species collected from environmental air samples in Portugal-molecular identification, antifungal susceptibility and sequencing of cyp51A gene on A. fumigatus sensu stricto itraconazole resistant.

Monteiro C, Pinheiro D, Maia M, Faria MA, Lameiras C, Pinto E.

J Appl Microbiol. 2019 Apr;126(4):1140-1148. doi: 10.1111/jam.14217. Epub 2019 Feb 27.

PMID:
30735287
17.

In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.

Arendrup MC, Jensen RH, Cuenca-Estrella M.

Antimicrob Agents Chemother. 2015 Nov 9;60(1):532-6. doi: 10.1128/AAC.02336-15. Print 2016 Jan.

18.
19.

The strength of synergistic interaction between posaconazole and caspofungin depends on the underlying azole resistance mechanism of Aspergillus fumigatus.

Mavridou E, Meletiadis J, Rijs A, Mouton JW, Verweij PE.

Antimicrob Agents Chemother. 2015 Mar;59(3):1738-44. doi: 10.1128/AAC.04469-14. Epub 2015 Jan 12.

20.

The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus.

Fraczek MG, Bromley M, Buied A, Moore CB, Rajendran R, Rautemaa R, Ramage G, Denning DW, Bowyer P.

J Antimicrob Chemother. 2013 Jul;68(7):1486-96. doi: 10.1093/jac/dkt075. Epub 2013 Apr 10.

PMID:
23580559

Supplemental Content

Support Center